Roferon-A Drug Interactions
Currently displaying a list of 275 drugs known to interact with Roferon-A (interferon alfa-2a).
- 41 major drug interactions
- 230 moderate drug interactions
- 4 minor drug interactions
Medications known to interact with Roferon-A
Note: Showing generic names only.
- adalimumab
- ado-trastuzumab emtansine
- aldesleukin
- alemtuzumab
- amifampridine
- aminophylline
- amiodarone
- anagrelide
- anisindione
- asenapine
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atezolizumab
- atorvastatin
- auranofin
- aurothioglucose
- avatrombopag
- avelumab
- axicabtagene ciloleucel
- azathioprine
- baricitinib
- bedaquiline
- benazepril
- bendamustine
- benznidazole
- bexarotene
- black cohosh
- bleomycin
- bortezomib
- brentuximab
- brexucabtagene autoleucel
- bupropion
- busulfan
- cabazitaxel
- calaspargase pegol
- cannabidiol
- capecitabine
- captopril
- carboplatin
- carfilzomib
- carmustine
- cemiplimab
- cerivastatin
- certolizumab
- chlorambucil
- chloramphenicol
- chloramphenicol ophthalmic
- chloramphenicol otic
- chloroquine
- ciltacabtagene autoleucel
- cisplatin
- cladribine
- clofarabine
- clozapine
- colchicine
- cosibelimab
- crizotinib
- cyclophosphamide
- cytarabine liposomal
- dacarbazine
- daclizumab
- dactinomycin
- dapsone
- daunorubicin
- daunorubicin liposomal
- decitabine
- deferiprone
- denosumab
- deucravacitinib
- dicumarol
- didanosine
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- disulfiram
- docetaxel
- dostarlimab
- doxorubicin
- doxorubicin liposomal
- durvalumab
- efavirenz
- efbemalenograstim alfa
- eflapegrastim
- elotuzumab
- elranatamab
- eltrombopag
- enalapril
- enalaprilat
- enfortumab vedotin
- epirubicin
- eribulin
- etanercept
- ethambutol
- ethionamide
- etoposide
- etranacogene dezaparvovec
- etrasimod
- etravirine
- evening primrose
- fezolinetant
- fidanacogene elaparvovec
- filgrastim
- fingolimod
- floxuridine
- fludarabine
- fluorouracil
- fluphenazine
- fluvastatin
- fosinopril
- ibritumomab
- idarubicin
- idecabtagene vicleucel
- idelalisib
- ifosfamide
- imatinib
- infliximab
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- interferon beta-1a
- interferon beta-1b
- iodoquinol
- iohexol
- iomeprol
- iopamidol
- ipilimumab
- isatuximab
- isoniazid
- ixabepilone
- ixazomib
- leflunomide
- levobupivacaine
- levodopa
- levoketoconazole
- lindane topical
- linezolid
- lisinopril
- lisocabtagene maraleucel
- lomitapide
- lomustine
- loncastuximab tesirine
- lovastatin
- lurbinectedin
- mechlorethamine
- melatonin
- melphalan
- melphalan flufenamide
- mercaptopurine
- methotrexate
- metrizamide
- metronidazole
- mipomersen
- mirvetuximab soravtansine
- mitomycin
- mitoxantrone
- moexipril
- monomethyl fumarate
- mosunetuzumab
- paclitaxel
- paclitaxel protein-bound
- palifermin
- pegaspargase
- pegfilgrastim
- peginterferon alfa-2a
- peginterferon alfa-2b
- peginterferon beta-1a
- pembrolizumab
- pemetrexed
- penpulimab
- pentostatin
- perindopril
- pexidartinib
- pimozide
- pitavastatin
- polatuzumab vedotin
- polyethylene glycol 3350 with electrolytes
- pomalidomide
- ponatinib
- ponesimod
- pravastatin
- radium 223 dichloride
- ramipril
- rasagiline
- red yeast rice
- remdesivir
- repotrectinib
- retifanlimab
- rifampin
- ritlecitinib
- roflumilast
- roflumilast topical
- ropeginterferon alfa-2b
- ropinirole
- rosuvastatin
- ruxolitinib
- samarium sm 153 lexidronam
- sargramostim
- secnidazole
- selinexor
- simvastatin
- siponimod
- sipuleucel-T
- sodium phosphate p32
- stavudine
- stiripentol
- streptozocin
- strontium-89 chloride
- tacrolimus topical
- tafasitamab
- talquetamab
- tarlatamab
- tbo-filgrastim
- teclistamab
- telbivudine
- telisotuzumab vedotin
- temozolomide
- teniposide
- teriflunomide
- thalidomide
- theophylline
- thioguanine
- thiotepa
- tinidazole
- tisagenlecleucel
- tislelizumab
- tisotumab vedotin
- tocilizumab
- tofacitinib
- topotecan
- toripalimab
- trabectedin
- tramadol
- trandolapril
- tremelimumab
- treosulfan
- valganciclovir
- valoctocogene roxaparvovec
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- voclosporin
Roferon-A disease interactions
There are 10 disease interactions with Roferon-A (interferon alfa-2a) which include:
- renal dysfunction
- autoimmune diseases
- hepatic dysfunction
- cardiac disease
- CNS dysfunction
- depression
- thyroid dysfunction
- diabetes mellitus
- myelosuppression
- peripheral neuropathy
More about Roferon-A (interferon alfa-2a)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antineoplastic interferons
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Taxol
Taxol (paclitaxel) is used to treat breast cancer, lung cancer, and ovarian cancer. Includes Taxol ...
Pomalyst
Pomalyst (pomalidomide) is used to treat multiple myeloma and AIDS-related Kaposi sarcoma. Includes ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Doxil
Doxil is used for kaposi's sarcoma, multiple myeloma, ovarian cancer
Velban
Velban is used for breast cancer, cancer, choriocarcinoma, histiocytosis, hodgkin's lymphoma ...
Intron A
Intron A is used for angioblastoma, condylomata acuminata, conjunctival mucosa-associated lymphoid ...
Doxorubicin liposomal
Doxorubicin liposomal is used for kaposi's sarcoma, multiple myeloma, ovarian cancer
Interferon alfa-2b
Interferon alfa-2b is used for angioblastoma, condylomata acuminata, conjunctival mucosa-associated ...
Vinblastine
Vinblastine is used for breast cancer, cancer, choriocarcinoma, histiocytosis, hodgkin's lymphoma ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.